After seeing the struggles her patients faced living with type 1 diabetes, Dr. Tina Gupta was compelled to do more to help. She left clinical practice and joined Vertex Pharmaceuticals, a company researching treatment therapies that replace non-functioning beta cells with stem-cell- derived cells to try to reduce or eliminate the need for people with T1D to take insulin.
read more →
Vertex Pharmaceuticals is looking for people living with type 1 diabetes to participate in a study of an investigational cell-based therapy to see if it could potentially reduce or eliminate the need for people with type 1 to take insulin.
read more →
Vertex Pharmaceuticals is relatively new to the type 1 diabetes space, and they are working hard to understand what it’s like for people to live with T1D so they can develop transformative therapies. They’re currently investigating and advancing cell therapies aimed at treating an underlying cause of type 1 – the absence of insulin-producing cells.
read more →
Our international panel of diabetes experts discussed highlights from the ADA’s Scientific Sessions, and lead a Q&A on some of the most important advances in diabetes.
read more →
It is now possible to manufacture insulin-producing cells in a lab, using multiple different techniques developed by a multitude of researchers. What does this mean for people living with type 1 diabetes, or who are insulin dependent?
read more →
